Comments on National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China(English version)  

作　　者：Yong Yang Zhaoya Gao Jin Gu 

机构地区：[1]Department of Gastrointestinal Surgery,Peking University Shougang Hospital,Beijing 100144,China [2]Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China

出　　处：《Chinese Journal of Cancer Research》2023年第5期431-432,共2页中国癌症研究（英文版）

摘　　要：Colorectal cancer(CRC)has always been one of the most common malignant tumors in the world,and the incidence and mortality have been on the rise in China.The Cancer Statistics Report of China in 2020 showed that the incidence and mortality of CRC ranked second and fifth among all malignant tumors,with 555,000 new cases and 286,000 deaths,respectively.Among them,cities were much higher than rural areas,and the incidence of colon cancer had increased significantly.Most patients were already in the advanced stage at the time of diagnosis.

关 键 词：MORTALITY diagnosis cancer 

分 类 号：R73[医药卫生—肿瘤]